KALY Announces A New Step Forward For Its Cannabis Extraction Lab
The continuing liberalization of cannabis laws such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing.
Read More
Category: Biomedical
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
The FDA provided feedback supportive of CURE’s clinical development plans for its CUREfilm Blue, a soluble thin film for oral administration of sildenafil citrate (Viagra™) to treat erectile dysfunction (ED).
Read More
KALY Initiates Phase Two Cannabis Extract COPD Treatment Study
A report on the first primate study from Professor Jeffry Osbourn is coming soon. DALLAS, March...
Read More
ICC International Cannabis Corp. Competing in Explosive Worldwide Cannabis Market with Unique Global Strategy
NEW YORK, NY, Feb. 22, 2019 (GLOBE NEWSWIRE) — Make no mistake about it the growth of the...
Read MoreGET LISTED
